Skip to content

Cell Cycle Regulation

Latest questions in this category.

89 questions

Which kinase is involved in regulating the initiation of DNA replication in S phase?

Initiation of DNA replication at licensed origins depends on two kinase families that separate licensing from firing. DDK kinase complex Dbf4-Cdc7 phosphorylates MCM2-7 helicase at N-terminal serine-threonine clusters, promoting Cdc45 recruitment. Second trigger is S-phase CDK activity supplied by cyclin E-CDK2 that peaks at G1/S border and cyclin A-CDK2 that sustains activity into S phase. Cyclin E-CDK2 phosphorylates Treslin/TICRR at threonine 969, MTBP, RecQL4, and orthologs of yeast Sld2 and Sld3, enabling their binding to BRCT repeats of TopBP1 and assembly of Cdc45-MCM-GINS active helicase known as CMG that unwinds duplex DNA and recruits DNA polymerases alpha, delta, epsilon, and Ctf4 for leading and lagging strand synthesis. CDK2 also phosphorylates licensing factors Cdc6 and Cdt1 for nuclear export and SCF-dependent proteolysis to prevent re-licensing. CDK4/6 acts indirectly in early G1 to induce cyclin E transcription via Rb phosphorylation. Inhibition of CDK2 blocks origin firing without affecting cyclin D accumulation. This circuitry is highly conserved across eukaryotes, integrating growth factor signals, DNA damage surveillance, and developmental cues, and its disruption frequently underlies oncogenesis, providing targets for checkpoint inhibitors and cancer therapeutics.

Ref: Labib, Genes & Dev 2010, Origin Activation. Limas & Cook, Genes & Dev 2019, CDK Roles S Phase.

Which protein is degraded by APC to trigger chromosome separation?

Chromatid cohesion must be maintained until synchronous separation at anaphase, requiring protection against premature cleavage. Securin, also called pituitary tumor transforming gene PTTG, functions as dual inhibitor and chaperone of separase. Securin sequence contains D-box and KEN motifs for APC/C recognition and binds separase HEAT repeats, occluding catalytic triad. Accumulation during S and G2 concentrates at centromeres. At metaphase, APC/C-Cdc20 polyubiquitinates securin, triggering rapid proteasomal degradation within five to ten minutes, concentration dropping precipitously. Simultaneously cyclin B destruction inactivates CDK1 that also phosphorylates separase inhibitory sites, fully unleashing protease. Liberated separase translocates to chromosomes and cleaves Rad21/Scc1 kleisin at conserved EXXR motifs after glutamate, generating N- and C-terminal fragments unable to maintain ring closure. This opens cohesin, allowing kinetochore microtubules to pull sisters to opposite poles. Expression of non-degradable securin mutant with mutated D-box prevents cohesion loss and arrests cells in metaphase with intact cohesion. This circuitry is highly conserved across eukaryotes, integrating growth factor signals, DNA damage surveillance, and developmental cues, and its disruption frequently underlies oncogenesis, providing targets for checkpoint inhibitors and cancer therapeutics.

Ref: Uhlmann et al., Nature 1999, Separase Cohesin Cleavage. Alberts 7th ed., Chapter 17, Securin.

Wee1 kinase inhibition in G2 phase leads to:

G2 progression is gated by inhibitory phosphorylation of master mitotic kinase CDK1 that prevents premature mitotic entry while last preparations complete. Nuclear kinase Wee1 and membrane-associated Myt1 phosphorylate CDK1 subunit within cyclin B-CDK1 complex at Tyr15 and Thr14 within ATP-binding loop, rendering kinase catalytically inactive despite abundant cyclin B synthesized during G2, allowing centrosome maturation, Golgi segregation, and DNA repair synthesis to proceed. At G2/M border, dual-specificity phosphatases Cdc25A/B/C remove these phosphates, causing explosive autoamplification where CDK1 phosphorylates Cdc25 to activate it and phosphorylates Wee1 to inhibit it. Pharmacologic inhibition or siRNA depletion of Wee1 eliminates inhibitory phosphate, leading to immediate activation of cyclin B-CDK1 before replication fully completed or damage repaired, driving cells into mitosis with under-replicated DNA, premature chromosome condensation, pulverization, and activation of mitotic catastrophe program. This vulnerability underlies therapy where Wee1 inhibitors enhance genotoxic chemotherapy efficacy in p53-deficient cancers. This circuitry is highly conserved across eukaryotes, integrating growth factor signals, DNA damage surveillance, and developmental cues, and its disruption frequently underlies oncogenesis, providing targets for checkpoint inhibitors and cancer therapeutics.

Ref: Harper & Elledge, Mol Biol Cell 2007, Wee1 Control. Alberts 7th ed., Chapter 17, CDK1 Regulation.

Which regulatory factor is crucial for the metaphase-to-anaphase transition?

Metaphase to anaphase transition represents irreversible commitment executed by APC/C bound to Cdc20 coactivator. Throughout prometaphase chromosomes attach via kinetochores, generating unattached kinetochore signal converting Mad2 to active inhibitor forming mitotic checkpoint complex with BubR1, Bub3, and Cdc20 that binds APC/C core to block E2 recruitment. Upon achievement of biorientation of all chromosomes and establishment of tension, checkpoint protein recruitment stops, complex disassembles, and free Cdc20 associates with phosphorylated APC/C previously primed by CDK1 and Plk1. Active APC/C-Cdc20 polyubiquitinates securin and cyclin B with K11 chains for proteasomal destruction. Securin normally binds and locks separase protease in inactive conformation together with cyclin B-CDK1 phosphorylation. Degradation liberates separase that cleaves kleisin Rad21 subunit of cohesin ring embracing sister chromatids since S phase, opening ring, while cyclin B destruction drops CDK1 activity permitting phosphatase activation and mitotic exit. Blocking securin degradation prevents chromatid separation. This circuitry is highly conserved across eukaryotes, integrating growth factor signals, DNA damage surveillance, and developmental cues, and its disruption frequently underlies oncogenesis, providing targets for checkpoint inhibitors and cancer therapeutics.

Ref: Peters et al., Cell 1998, APC/C Regulation. Musacchio, Nat Rev Mol Cell Biol 2011, Anaphase.

What is the function of Cdc6 and Cdt1 in DNA replication?

Pre-replication complex formation establishes replication competence before S phase, separating helicase loading from activation. Origin recognition complex ORC marks replication origins throughout cell cycle at AT-rich sequences. In late mitosis and early G1 when CDK activity minimal due to APC/C-Cdh1 mediated cyclin degradation, AAA+ ATPase Cdc6 binds ORC and recruits chaperone Cdt1 bound to single hexamer of MCM2-7 helicase. ATP hydrolysis by Cdc6 and ORC opens MCM ring, allowing encirclement of double-stranded DNA and formation of inactive double hexamer encircling DNA in head-to-head orientation, designated licensed origin. No DNA unwinding occurs. At G1/S transition, DDK kinase Dbf4-Cdc7 and CDK2 phosphorylate MCM and factors Sld2, Sld3, and Dpb11, recruiting Cdc45 and GINS to form active CMG helicase that unwinds DNA and recruits polymerases alpha, delta, and epsilon. Without Cdc6 and Cdt1, MCM loading fails and S phase cannot start, while their subsequent CDK-dependent degradation and nuclear exclusion prevent re-licensing in same cycle.

Ref: Bell & Labib, Genes & Dev 2016, Pre-RC Assembly. Alberts 7th ed., Chapter 5, Replication Licensing.

In the regulation of DNA replication, which factor ensures that origins fire only once per cycle?

Eukaryotes must replicate each DNA segment exactly once per cell cycle to avoid re-replication which causes double-strand breaks and genomic instability. Origin licensing is restricted to G1 when CDK activity low: ORC, Cdc6, and Cdt1 load double hexamer of MCM2-7 helicase. At S onset, CDK and DDK activate helicase, but re-loading must be blocked. Geminin protein accumulating from S through early mitosis directly binds Cdt1 through extended coiled-coil domain, sterically occluding MCM-interacting surface and preventing second helicase loading. Concurrently, cyclin A-CDK2 phosphorylates Cdt1 and Cdc6, promoting nuclear export and SCF-mediated ubiquitination. APC/C-Cdh1 degrades geminin in late mitosis and G1, resetting system to allow new licensing for next cycle. Depletion of geminin in human cells triggers partial re-replication, ATR checkpoint activation, and apoptosis. Overexpression of geminin and Cdt1 observed in many tumors correlates with aneuploidy and poor prognosis, confirming its role as essential guard of single genome duplication. This circuitry is highly conserved across eukaryotes, integrating growth factor signals, DNA damage surveillance, and developmental cues, and its disruption frequently underlies oncogenesis, providing targets for checkpoint inhibitors and cancer therapeutics.

Ref: McGarry & Kirschner, Cell 1998, Geminin Function. Fragkos et al., Nature Rev Mol Cell Biol 2015.

Which molecule directly targets p27 for ubiquitin-mediated degradation?

Abundance of p27 is controlled post-translationally rather than transcriptionally, illustrating CDK-regulated proteolysis that sharpens G1/S transition. Late in G1, cyclin E-CDK2 phosphorylates p27 intrinsically disordered C-terminus at threonine 187. This phosphate forms high-affinity interaction with WD40 domain of Skp2, F-box protein assembled into SCF-Skp2 E3 ligase with Skp1 adaptor, Cullin1 scaffold, Rbx1 RING finger recruiting Ubc3 E2 enzyme, plus Cks1 cofactor that bridges CDK and F-box. SCF catalyzes formation of K48-linked polyubiquitin chains on p27 lysines, marking it for rapid degradation by 26S proteasome within minutes. Transcriptional induction of Skp2 via Myc and PI3K pathways by mitogens reinforces degradation. Unlike mitotic cyclins degraded by APC/C, p27 depends distinctly on SCF family ensuring its destruction paced directly by CDK activity itself, generating positive feedback. Persistent p27 due to Skp2 loss causes G1 arrest, while Skp2 overexpression reduces p27 in many cancers. This circuitry is highly conserved across eukaryotes, integrating growth factor signals, DNA damage surveillance, and developmental cues, and its disruption frequently underlies oncogenesis, providing targets for checkpoint inhibitors and cancer therapeutics.

Ref: Carrano et al., Nature Cell Biology 1999, SCF-Skp2 Targets p27. Alberts 7th ed., Chapter 3.

The role of p27 in G1 phase is to:

p27Kip1 product of CDKN1B gene exemplifies Cip/Kip family that imposes G1 arrest and integrates nutrient availability with size control. In quiescent and early G1 cells, p27 accumulates due to low proteasomal turnover and binds cyclin E-CDK2 heterodimer, inserting 3_10 helix into ATP-binding pocket, preventing catalysis and blocking Rb phosphorylation, maintaining E2F repression. This prevents premature S-phase entry when growth factors limited. Mitogen signaling induces cyclin D-CDK4/6 complexes that sequester p27 in trimeric assembly without fully inhibiting them, lowering free p27 pool. Subsequent phosphorylation of p27 at threonine 187 by progressively activated cyclin E-CDK2 creates high-affinity phosphodegron recognized by F-box protein Skp2 assembled in SCF complex with Skp1, Cul1, Rbx1, and accessory Cks1. SCF-Skp2 polyubiquitinates p27 targeting it to 26S proteasome. Declining p27 levels unleash full CDK2 activity, hyperphosphorylating Rb and committing to DNA replication when nutrient conditions favorable. This circuitry is highly conserved across eukaryotes, integrating growth factor signals, DNA damage surveillance, and developmental cues, and its disruption frequently underlies oncogenesis, providing targets for checkpoint inhibitors and cancer therapeutics.

Ref: Sherr & Roberts, Genes & Dev 2004, p27 Biology. Morgan, Cell Cycle, Chapter 4, G1 Control.

What is the role of the Spindle Assembly Checkpoint (SAC)?

Chromosome missegregation produces aneuploidy implicated in tumorigenesis, congenital disorders, and embryonic lethality, necessitating surveillance by spindle assembly checkpoint. Sensor is kinetochore assembled on CENP-A containing centromeric nucleosomes that binds microtubule plus ends via Ndc80 complex. Unattached kinetochores act as catalytic platforms where Mad1-Mad2 heterotetramer converts soluble open Mad2 into closed conformation that binds Cdc20. Together with BubR1, Bub3, and Bub1 phosphorylated by Mps1 kinase, they generate diffusible mitotic checkpoint complex that inhibits APC/C-Cdc20 throughout cytoplasm, blocking ubiquitination of securin and cyclin B. Aurora B kinase at inner centromere destabilizes low-tension syntelic or merotelic attachments by phosphorylating Ndc80, creating unattached kinetochores that re-engage checkpoint. Upon biorientation with sister kinetochores attached to opposite poles under tension, Mad1-Mad2 recruitment ceases, checkpoint complex disassembles, APC/C activates, and synchronous anaphase proceeds, ensuring equal genome distribution. This circuitry is highly conserved across eukaryotes, integrating growth factor signals, DNA damage surveillance, and developmental cues, and its disruption frequently underlies oncogenesis, providing targets for checkpoint inhibitors and cancer therapeutics.

Ref: Musacchio, Current Biology 2015, SAC Mechanism. Alberts 7th ed., Chapter 17, Mitosis Quality.

The protein p16 (INK4) primarily inhibits:

INK4 family represents dedicated inhibitors of CDK4 and CDK6 distinguishing them from Cip/Kip family that target cyclin E-CDK2 and cyclin A-CDK2. p16INK4a product of CDKN2A locus contains four ankyrin repeats forming elongated structure that binds CDK6 opposite cyclin-binding interface, inducing distortion of ATP-binding pocket and preventing association with cyclin D. Since cyclin D-CDK4/6 is earliest kinase phosphorylating Rb in response to mitogens, its inhibition maintains Rb in hypophosphorylated active repressor state bound to E2F, arresting cell before restriction point. Genetic inactivation through homozygous deletion, nonsense mutation, or promoter CpG hypermethylation occurs at high frequency in melanoma familial syndromes, pancreatic ductal adenocarcinoma, glioblastoma multiforme, and esophageal cancers, leading to uncontrolled Rb phosphorylation. Clinically, pharmacologic mimics of p16 action including palbociclib, ribociclib, and abemaciclib selectively inhibit CDK4/6, restoring Rb function and inducing G1 arrest in estrogen receptor-positive breast cancer, demonstrating translational exploitation. This circuitry is highly conserved across eukaryotes, integrating growth factor signals, DNA damage surveillance, and developmental cues, and its disruption frequently underlies oncogenesis, providing targets for checkpoint inhibitors and cancer therapeutics.

Ref: Sherr & Roberts, Genes & Dev 1999, INK4 Family Biology. Alberts 7th ed., Chapter 20.

Which kinase activates APC/C-Cdc20 to trigger the metaphase-anaphase transition?

Assembly and activation of APC/C-Cdc20 must occur only after CDK1 has driven mitotic entry, ensuring anaphase does not initiate prematurely. During G2, APC/C exists in unphosphorylated inactive conformation with weak affinity for Cdc20, while Cdc20 itself is kept inactive by CDK inhibitory phosphorylation and binding to checkpoint protein Mad2. Upon entry into mitosis, cyclin B-CDK1, the master mitotic kinase, phosphorylates multiple subunits including APC1 at loop region, APC3, and APC6, inducing conformational rearrangement exposing C-box binding groove. Polo-like kinase Plk1 adds further phosphorylations enhancing Cdc20 docking. This priming step does not yet trigger substrate destruction because mitotic checkpoint complex still occupies Cdc20 until chromosome biorientation. Once checkpoint satisfied, pre-phosphorylated APC/C-Cdc20 unleashes polyubiquitination of securin and cyclin B. This dependency couples kinase surge to proteolysis, guaranteeing that chromosome condensation and spindle formation precede sister chromatid separation, preserving order of mitotic events. This circuitry is highly conserved across eukaryotes, integrating growth factor signals, DNA damage surveillance, and developmental cues, and its disruption frequently underlies oncogenesis, providing targets for checkpoint inhibitors and cancer therapeutics.

Ref: Lodish et al., Molecular Cell Biology, 9th ed., Chapter 20: Mitotic Activation of APC/C.

The APC/C-Cdh1 complex is required for:

Specificity and timing of APC/C activity arise from sequential association with two adaptors, Cdc20 and Cdh1, both containing seven WD40 repeats forming beta-propeller that binds D-box and KEN motifs. During prometaphase and metaphase, APC/C-Cdc20 polyubiquitinates securin and cyclin B to trigger anaphase and mitotic exit. At telophase, cyclin B degradation reduces CDK1 activity, allowing Cdc14 phosphatase to dephosphorylate Cdh1, enabling its binding to APC/C core. APC/C-Cdh1 then operates from late mitosis through entire G1, continuously ubiquitinating mitotic cyclins A and B, mitotic kinases Polo and Aurora, Geminin inhibitor of licensing, and even Cdc20 itself, ensuring low CDK environment. Low CDK permits pre-replication complex formation consisting of ORC, Cdc6, Cdt1, and double hexamer of MCM2-7 helicase loaded at origins. As cyclin E-CDK2 accumulates at G1/S, it phosphorylates Cdh1 creating 14-3-3 sites, displacing it from APC/C and inactivating ligase, allowing S-phase cyclin accumulation and transition to next cycle. This circuitry is highly conserved across eukaryotes, integrating growth factor signals, DNA damage surveillance, and developmental cues, and its disruption frequently underlies oncogenesis, providing targets for checkpoint inhibitors and cancer therapeutics.

Ref: Peters, Nature Reviews Mol Cell Biol 2006, APC/C Mechanisms. Alberts 7th ed., Chapter 17.